| 摘要 |
FIELD: medicine.SUBSTANCE: invention represents a medication for reduction of the hepatitis C virus reproduction, which contains at least one polyprenyl phosphate or polyprenyl pyrophosphate with a number of isoprene units from 9 to 20, mainly from 13 to 18, either a mixture of different polyprenyl phosphates or different polyprenyl pyrophosphates, or a mixture of different polyprenyl phosphates and polyprenyl pyrophosphates with a specified number of isoprene units in a weight ratio from 5:1 to 20:1.EFFECT: reduction of toxicity, extension of action on most strains of hepatitis C viruses and preservation of an anti-viral action in case of long-term storage.4 cl, 1 tbl, 2 dwg |
